Home Cart Sign in  
Chemical Structure| 25459-91-0 Chemical Structure| 25459-91-0

Structure of Demethyleneberberine
CAS No.: 25459-91-0

Chemical Structure| 25459-91-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Demethyleneberberine (DMB), a component of CPC, is reported to treat alcoholic liver disease as a novel natural mitochondria-targeted antioxidant.

Synonyms: DMB

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Demethyleneberberine

CAS No. :25459-91-0
Formula : C19H18NO4
M.W : 324.35
SMILES Code : OC1=C(O)C=C2CC[N+]3=C(C=C4C=CC(OC)=C(C4=C3)OC)C2=C1
Synonyms :
DMB
MDL No. :MFCD22417296

Safety of Demethyleneberberine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Demethyleneberberine

epigenetics
PI3K-AKT
pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HSC-T6 cells 10, 20, 40 µM 48 h Inhibited HSC-T6 cell proliferation and promoted apoptosis by suppressing NF-κB signaling pathway Int J Mol Sci. 2016 Jun 30;17(7):1036
RAW264.7 cells 10 μM 12 h To evaluate the inhibitory effect of DMB on LPS-induced TLR4 signaling pathway Front Immunol. 2023 Apr 24;14:1130404

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Healthy male SD rats Intragastric and intravenous injection 20 and 40 mg/kg Single administration To investigate the pharmacokinetic parameters, tissue distribution, and excretion of demethyleneberberine in rats and mice. Results showed that demethyleneberberine reached peak plasma concentration within 5 minutes after intragastric administration, with higher bioavailability than berberine, and a total excretion rate of 7.28~9.77%. Molecules. 2023 Nov 23;28(23):7725
ICR mice Thioacetamide (TAA)-induced hepatic fibrosis model Intraperitoneal injection 10 mg/kg and 20 mg/kg Daily administration for 10 weeks DMB significantly attenuated TAA-induced hepatic fibrosis, reduced serum ALT and AST levels, increased serum ALB levels, and inhibited HSC activation and collagen synthesis Int J Mol Sci. 2016 Jun 30;17(7):1036
Sprague Dawley rats and C57BL/6 mice TNBS-induced colitis model and LPS-induced acute sepsis model Oral 100 mg/kg/day and 200 mg/kg/day Once daily for 7 days To evaluate the therapeutic effect of DMB on TNBS-induced colitis and LPS-induced acute sepsis Front Immunol. 2023 Apr 24;14:1130404

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.42mL

3.08mL

1.54mL

30.83mL

6.17mL

3.08mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories